# FDA Inspection 1201009 - LifeShare Blood Center - March 10, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/lifeshare-blood-center/c663f555-f0f3-4c3d-9a7d-2c96637aeb8c
Source feed: FDA_Inspections

> FDA Inspection 1201009 for LifeShare Blood Center on March 10, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201009
- Company Name: LifeShare Blood Center
- Inspection Date: 2023-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1201009 - 2023-03-10](https://www.globalkeysolutions.net/records/fda_inspections/lifeshare-blood-center/68170273-b1f8-4b69-b36d-743e619aef66)
- [FDA Inspection 1112129 - 2019-11-19](https://www.globalkeysolutions.net/records/fda_inspections/lifeshare-blood-center/70d11cc8-2e60-45ce-a050-83dc034332e6)
- [FDA Inspection 1022399 - 2017-07-26](https://www.globalkeysolutions.net/records/fda_inspections/lifeshare-blood-center/6e044edd-dccd-49b6-bb8c-830551ec0196)
- [FDA Inspection 887057 - 2014-07-10](https://www.globalkeysolutions.net/records/fda_inspections/lifeshare-blood-center/f84ce767-4541-4f13-853e-9a105a6ac0bc)
- [FDA Inspection 759971 - 2011-12-21](https://www.globalkeysolutions.net/records/fda_inspections/lifeshare-blood-center/56d7f6f0-c978-447d-b6b0-ac70dffd9128)

Company: https://www.globalkeysolutions.net/companies/lifeshare-blood-center/e1707c60-8e43-4429-b543-0a9e2e85cdc6

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d